search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
ADAPTING EXPERIMENTATION AND TESTING


demonstrated success in reducing points of contact, streamlining the coordination process, integrating capabilities and improving the consistency and quality of information dissemination.


Te EI Cell’s heterodox approach also embraces participa- tion by industry partners in experimentation events alongside USAMRDC scientists and warfighters, providing a channel for USAMRDC to inform and influence industry best practices. “When we have innovative partners that come out into the field with us—and many times, they are veterans themselves—they find that things are very different from how they envisioned it in their labs,” said Nuckols. “I think that kind of experience is very informative to industry and in some cases, it may even help them be more competitive. Te lessons learned and gathered at an event will help not only those who participated, but also ulti- mately the defense medical industry as a whole.”


ARCTIC EDGE 2024: A CASE STUDY IN COORDINATION Te EI Cell coordinated the efforts of four DRUs and a collabo- rating partner, the Naval Health Research Center, to test seven technologies at Arctic Edge 2024, the annual exercise led by the U.S. Northern Command at Joint Base Elmendorf-Richardson (JBER) in Alaska, in February and March 2024. Represen- tatives of the Diagnostic Systems Division of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) tested three field-forward devices for detecting the presence of pathogens—a real-time polymerase chain reaction (PCR) ther- mocycler, a lateral flow immunoassay and a portable targeted genomic sequencer—in extreme cold-weather conditions. Teir participation was part of the division’s efforts to get commercial off-the-shelf testing devices into the hands of service members


The EI Cell has


FREEZE FRAME


From left, Paul Kallgren, William Dorman and Capt. Ian Davis, all with USAMRIID’s Diagnostic Systems Division, test PCR thermocyclers and handheld assays before sunrise to achieve the coldest possible environment during Arctic Edge 2024. Results from the exercise will be used to develop initial protocols that will be tested in subsequent exercises.


who can stress-test them in the field under real-world condi- tions—to “kick the tires,” in the team’s parlance—so that they can be deployed more quickly than by going through traditional acquisition processes.


Cmarik worked with Maj. John Sellers, the USAMRIID team’s lead, and representatives from the U.S. Air Force to ensure they had the correct points of contact and other necessary information for delivering supplies, reagents and personnel to JBER. She also coordinated with the exercise organizers to ensure the team had the resources they needed when they arrived. Te team arrived at JBER a week early since their experiments would not need to be


https://asc.ar my.mil 25


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148